Aug 5, 2025· Comment from Consumer Healthcare Products Association· FDA-2025-N-1359-0003
Please find attached comments from the Consumer Healthcare Products Association on 'Over-the-Counter Monograph Condition B001: Single-Unit or Unit-Dose Containers for Over-the-Counter Monograph Drugs in Orally Disintegrating Tablet and Film Dosage Forms'.